• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Osiris Therapeutics, Inc. (OSIR)

    -NasdaqGM
    19.27 Down 0.29(1.48%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:19.56
    Open:19.53
    Bid:9.45 x 100
    Ask:22.49 x 200
    1y Target Est:23.50
    Beta:0.96
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:19.20 - 19.72
    52wk Range:11.87 - 20.70
    Volume:145,092
    Avg Vol (3m):157,759
    Market Cap:662.70M
    P/E (ttm):688.21
    EPS (ttm):0.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OSIRDown 1.48%662.70M
    ABTDown 0.22%73.56B
    BIIBDown 0.28%95.10B

    Key Statistics

    Forward P/E (1 yr):29.65
    P/S (ttm):9.50
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.41
    Quarterly EPS Est (Jun-15) :0.06
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback